Jones Financial Companies
LFCR icon

Jones Financial Companies’s Lifecore Biomedical LFCR Stock Holding History

Jones Financial Companies’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23
Closed -$188 – 4847
2025
Q4 		$188 Buy
+23
New +$170 ﹤0.01% 4274
2023
Q4 		– Sell
-1,000
Closed -$7.54K – 1023
2023
Q3 		$7.54K Hold
1,000
– – ﹤0.01% 497
2023
Q2 		$9.67K Hold
1,000
– – ﹤0.01% 470
2023
Q1 		$3.77K Hold
1,000
– – ﹤0.01% 534
2022
Q4 		$6K Hold
1,000
– – ﹤0.01% 527
2022
Q3 		$9K Hold
1,000
– – ﹤0.01% 434
2022
Q2 		$10K Buy
+1,000
New +$9.9K ﹤0.01% 476

Other funds holding LFCR

2L
22NW LP Seattle, Washington $105M AUM 38.33% 1-Year Est. Return
WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GC
Grizzlyrock Capital Chicago, Illinois $143M AUM 6.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jones Financial Companies's LFCR Position: Q1 2026 in Review

Jones Financial Companies sold out of Lifecore Biomedical (LFCR) in Q1 2026, closing a stake of 23 shares — an estimated $188 sold.

Jones Financial Companies first reported a position in LFCR in Q2 2022 and held it in 7 quarters. The position peaked at $10K in Q2 2022. 105 funds tracked by Wall St. Rank hold LFCR as of Q1 2026.

  • Jones Financial Companies reported no remaining Lifecore Biomedical position as of Q1 2026 after selling out during the quarter.
  • Jones Financial Companies sold 23 Lifecore Biomedical shares in Q1 2026, an estimated $188.
  • Jones Financial Companies first reported a position in Lifecore Biomedical in Q2 2022 and held it in 7 quarters.
  • Jones Financial Companies's Lifecore Biomedical position peaked at $10K in Q2 2022.
  • 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.